- Generic name
- Clonazepam
- Strength
- 1 mg/ml
- Dosage form
- Injection
- Manufactured by
- Opsonin Pharma Limited
Pase Injection
About Pase 1 mg/ml Injection
Made by Opsonin Pharma Limited, Pase is a injection whose active ingredient is Clonazepam. Pase 1 mg/ml injection is used to treat panic disorder, where a person has unexpected panic attacks and worries about further attacks.
There are 69 brands of Clonazepam listed in Bangladesh. The lowest listed price is Clonazepam 2 mg Tablet at ৳ 6 per unit.
What is Pase 1 mg/ml Injection?
Pase comes as a injection with 1 mg/ml of Clonazepam, from Opsonin Pharma Limited. Because it can cause drowsiness and other effects on the central nervous system, it is used under medical supervision. Pase is a prescription medicine, so it should only be taken on a doctor's advice, and the doctor sets the dose and how long it is taken. Tell your doctor about your other medicines and health conditions before you start.
Uses of Pase
Pase 1 mg/ml injection is used to treat panic disorder, where a person has unexpected panic attacks and worries about further attacks. Pase 1 mg/ml injection is used as an adjunct in the treatment of epilepsy, and Clonazepam is also used for panic disorder, with or without agoraphobia. Whether it suits a particular person depends on the doctor's assessment, so ask your doctor what it is being prescribed for in your case.
How to use Pase
Do not inject it yourself unless a doctor has shown you how. Pase is given as an injection by a healthcare professional. Take Pase 1 mg/ml injection exactly as the doctor tells you. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Pase
Drowsiness and unsteadiness are among the more frequent side effects of Clonazepam. Drowsiness and unsteadiness (ataxia) are common, and some people may notice behaviour changes. Drowsiness and unsteadiness (ataxia) are common, and behaviour problems have also been noted; in some cases these may lessen with time. Tell your doctor if any effect bothers you or does not go away; some effects need medical attention.
Safety and precautions
Nursing Mothers : Although the active ingredient of Clonazepam has been found to pass into the maternal milk in small amounts only, mothers undergoing treatment with this drug should not breastfeed. If there is a compelling indication for Clonazepam, breastfeeding should be discontinued. It should be borne in mind that both pregnancy itself and abrupt discontinuation of the medication can cause exacerbation of epilepsy. Keep out of reach of children.
Frequently asked questions
Why is Pase prescribed?
Pase 1 mg/ml injection is used to treat panic disorder, where a person has unexpected panic attacks and worries about further attacks. Pase 1 mg/ml injection is used as an adjunct in the treatment of epilepsy, and Clonazepam is also used for panic disorder, with or without agoraphobia.
How is Pase used?
Do not inject it yourself unless a doctor has shown you how. Pase is given as an injection by a healthcare professional.
What are the side effects of Pase?
Drowsiness and unsteadiness are among the more frequent side effects of Clonazepam. Drowsiness and unsteadiness (ataxia) are common, and some people may notice behaviour changes.
Is Pase safe for everyone?
Nursing Mothers : Although the active ingredient of Clonazepam has been found to pass into the maternal milk in small amounts only, mothers undergoing treatment with this drug should not breastfeed. If there is a compelling indication for Clonazepam, breastfeeding should be discontinued.
Also available as
Indications
It is also indicated ... Read moreIt is indicated for the treatment of panic disorder, with or without agoraphobia. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks.
It is also indicated alone or as an adjunct in the treatment of the Lennox-Gastaut Syndrome (petit mal variant), akinetic and myoclonic seizures. It may be indicated in patients with absence seizures (petit mal) who have failed to respond to succinimides.
The effectiveness of Clonazepam in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials. The physician who elects to use Clonazepam for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient.
Pharmacology
There are also animal data showing an effect of clonazepam on serotonin. Animal data and electroencephalographic investigations in man have shown that clonazepam rapidly suppresses many types of paroxysmal activity including the spike and wave discharge in absences seizures (petit mal), slow spike wave, generalized spike wave, spikes with temporal or other locations as well as irregular spikes and waves. Generalized EEG abnormalities are more regularly suppressed than focal abnormalities. According to these findings clonazepam has beneficial effects in generalized and focal epilepsies.
Dosage & Administration
- Adults: The initial dose for adults with seizure disorders should not exceed 1.5 mg/day divided into three doses. Dosage may be increased in increments of 0.5 to 1 mg every 3 days until seizures are adequately controlled or until side effects preclude any further increase. Maintenance dosage must be individualized for each patient depending upon response. Maximum recommended daily dose is 20 mg.
- The initial dose for adults with panic disorder is 0.25 mg given in two divided dose. An increase to the target dose for most patients of 1 mg/day may be made after 3 days.
- Pediatric Patients: In order to minimize drowsiness, the initial dose for infants and children (up to 10 years of age or 30 kg of body weight) should be between 0.01 and 0.03 mg/kg/day but not to exceed 0.05 mg/kg/day given in two or three divided doses.
Injection:
- Infants and children: half of a vial (0.5 mg) by slow IV injection or by IV infusion.
- Adults: 1 vial (1 mg) by slow IV injection or by IV infusion. This dose can be repeated as required (1-4 mg are usually sufficient to reverse the status). In adults, the rate of injection must not exceed 0.25 - 0.5 mg per minute (0.5-1.0 ml of the prepared solution) and a total dose of 10 mg should not be exceeded.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Nursing Mothers: Although the active ingredient of Clonazepam has been found to pass into the maternal milk in small amounts only, mothers undergoing treatment with this drug should not breastfeed. If there is a compelling indication for Clonazepam, breastfeeding should be discontinued.
Precautions & Warnings
Overdose Effects
Treatment: Monitor the patient’s vital signs and institute supportive measures as indicated by the patient’s clinical state. In particular, patients may require symptomatic treatment for cardiorespiratory effects or central nervous system effects. Further absorption should be prevented using an appropriate method e.g. treatment within 1-2 hours with activated charcoal. If activated charcoal is used airway protection is imperative for drowsy patients. In case of mixed ingestion gastric lavage may be considered, however not as a routine measure. If CNS depression is severe consider the use of flumazenil, a benzodiazepine antagonist. This should only be administered under closely monitored conditions. It has a short half-life (about an hour), therefore patients administered flumazenil will require monitoring after its effects have worn off. Flumazenil is to be used with extreme caution in the presence of drugs that reduce seizure threshold (e.g. tricyclic antidepressants). Refer to the prescribing information for flumazenil, for further information on the correct use of this drug.
Storage Conditions
Alternative brands of Clonazepam
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.